Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Statin Use Linked to Less Depression, Anxiety in ACOS Patients

Publish date:: July 23, 2019

Key clinical point: Adults with asthma–COPD overlap syndrome (ACOS) who used statins had a lower risk of anxiety and depression than nonstatin users.

Major finding: Statin users had significantly lower risks of anxiety (adjusted hazard ratio, 0.34) and depression (aHR, 0.36), compared with nonstatin users.

Study details: The data come from a retrospective cohort study of 1,252 statin users and 7,887 nonstatin users in Taiwan.

Disclosures: The study was supported by grants from a variety of organizations in Taiwan, China, and Japan. Dr. Jun-Jun Yeh and associates had no financial conflicts to disclose.

Citation:

Yeh J et al. J Affect Disord. 2019 Jun 15; 253:277-84.

This Week's Must Reads

Clinician Burnout Can Impact Quality of Care,

Survival at ‘overweight’ BMI surpasses ‘normal’,

Endometriosis is linked to adverse pregnancy outcomes,

Inadequate Glycemic Control in Type 1 Diabetes Leads to Increased Fracture Risk,

Inadequate glycemic control in type 1 diabetes leads to increased fracture risk,

Must Reads in Asthma

Statin Use Linked to Less Depression, Anxiety in ACOS Patients,

Don’t discount sleep disturbance for children with atopic dermatitis,

Antibiotic Therapy in Patients with Asthma, JAMA Intern Med; ePub 2019 Jan 28; Stefan, et al

Asthma Toolkit Improves Measures of Asthma Care, J Am Board Fam Med; 2019 Jan; Colborn, et al

Fractional Exhaled Nitric Oxide Testing in Asthma, Mayo Clin Proc; ePub 2017 Dec 20; Wang, et al